Who is the CEO of OABI? | Glauxie AI

Q: Who is the CEO of OABI?

OmniAb, Inc. (OABI) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Matthew W. Foehr. OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse... Employees: 89.

Q: What does OABI company do?

Learn what OABI does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling OABI?

Track recent insider buys and sells for OABI with transaction details, amounts, and trends.

Q: What sector is OABI in?

Find OABI sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of OABI?

🦉

OmniAb, Inc. (OABI)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMatthew W. Foehr

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics....

Key Executives

Name	Title
Bill Harriman	Senior Vice President of Antibody Discovery
Bob Chen	Senior Vice President of Discovery Systems
Charles S. Berkman	Chief Legal Officer & Secretary
Christel Iffland	Senior Vice President of Antibody Technologies
Cia McCaffrey	Senior Vice President of People & Talent
Kurt A. Gustafson	Executive Vice President of Finance & Chief Financial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

OABI Profile Financials

What does OABI company do? Are insiders buying or selling OABI? What sector is OABI in?